The European Citizens’ Initiative for Psychedelic-Assisted Therapies – launching at the start of 2025 – is aiming to collect one million signatures to urge the European...
A first-of-its-kind study has revealed that millions of Americans could benefit from psilocybin therapy if approved by the U.S.
Psychologists, therapists and counsellors play a fundamental role in treating common mental health disorders such as anxiety and depression.
An emerging body of evidence is showing psychedelics as promising treatments for mental health conditions, and psychiatry needs to be prepared for their arrival, say researchers.
A wealth of research is showing how psychedelic-assisted therapy holds promise for the treatment of mental health conditions such as depression, but what role does the...
A new paper has described the development of a self-directed intervention that harnesses digital technologies for psychedelic preparation.
Lykos Therapeutics, formerly MAPS Public Benefit Corporation, has announced it has received FDA acceptance and priority review for a New Drug Application (NDA) concerning its MDMA-assisted...
A new survey has revealed that over 79% of Canadians support psychedelic-assisted therapy for existential distress at the end of life.
Marking a historic first for Europe, the European Union has funded research into psychedelic therapy as part of its Horizon Europe programme.
Mindbloom has launched its new Mastermind Series of psychedelic programmes for overcoming heartbreak, burnout and other unique mental health challenges.
